Tumor exosomes inhibit differentiation of bone marrow dendritic cells

被引:344
作者
Yu, Shaohua
Liu, Cunren
Su, Kaihong
Wang, Jianhua
Liu, Yuelong
Zhang, Liming
Li, Chuanyu
Cong, Yingzi
Kimberly, Robert
Grizzle, William E.
Falkson, Carla
Zhang, Huang-Ge
机构
[1] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA
[5] Vet Adm Med Ctr, Birmingham, AL 35233 USA
关键词
D O I
10.4049/jimmunol.178.11.6867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The production of exosomes by tumor cells has been implicated in tumor-associated immune suppression. In this study, we show that, in mice, exosomes produced by TS/A murine mammary tumor cells target CD11b(+) myeloid precursors in the bone marrow (BM) in vivo, and that this is associated with an accumulation of myeloid precursors in the spleen. Moreover, we demonstrate that TS/A exosomes block the differentiation of murine myeloid precursor cells into dendritic cells (DC) in vitro. Addition of tumor exosomes at day 0 led to a significant block of differentiation into DC, whereas addition at later time points was less effective. Similarly, exosomes produced by human breast tumor cells inhibited the differentiation of human monocytes in vitro. The levels of IL-6 and phosphorylated Stat3 were elevated 12 h after the tumor exosome stimulation of murine myeloid precursors, and tumor exosomes were less effective in inhibiting differentiation of BM cells isolated from IL-6 knockout mice. Addition of a rIL-6 to the IL-6 knockout BM cell culture restored the tumor exosome-mediated inhibition of DC differentiation. These data suggest that tumor exosome-mediated induction of IL-6 plays a role in blocking BM DC differentiation.
引用
收藏
页码:6867 / 6875
页数:9
相关论文
共 46 条
[1]   Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen [J].
Aalamian, M ;
Tourkova, IL ;
Chatta, GS ;
Lilja, H ;
Huland, E ;
Huland, H ;
Shurin, GV ;
Shurin, MR .
JOURNAL OF UROLOGY, 2003, 170 (05) :2026-2030
[2]  
Almand B, 2000, CLIN CANCER RES, V6, P1755
[3]  
Andre F, 2001, ADV EXP MED BIOL, V495, P349
[4]   Tumor-derived exosomes:: a new source of tumor rejection antigens [J].
André, F ;
Scharz, NEC ;
Chaput, N ;
Flament, C ;
Raposo, G ;
Amigorena, S ;
Angevin, E ;
Zitvogel, L .
VACCINE, 2002, 20 :A28-A31
[5]   Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer [J].
Atreya, R ;
Neurath, MF .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) :187-195
[6]   Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation [J].
Bartz, Holger ;
Avalos, Nicole M. ;
Baetz, Andrea ;
Heeg, Klaus ;
Dalpke, Alexander H. .
BLOOD, 2006, 108 (13) :4102-4108
[7]  
Becker C, 2005, CELL CYCLE, V4, P217
[8]  
Büssing A, 1999, ANTICANCER RES, V19, P3953
[9]   Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML [J].
Cammenga, J .
LEUKEMIA, 2005, 19 (10) :1719-1728
[10]  
Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO